Discussion about this post

User's avatar
Jasmine Li's avatar

Really useful, thanks for writing!

Olivia Horbowy's avatar

That's a really useful taxonomy. I agree with your activity/outcome distinction. You can't effectively ban an outcome, you can only penalize it, but you can ban activities that are classified as ones that might lead to that outcome.

What we could extrapolate from SOX are successfully adopted measures like certification signed personally by executives, or also by responsible researchers, depending on how many levels of internal controls are adopted, with criminal responsibility for false certifications and full disclosure around anything that can't be certified with confidence, and the reasons. A human in the RSI loop with skin in the game, who personally attests that they reviewed, understood and approved each R&D run, is an entirely different person from one who simply clicks the "approve" button. Will that decrease the speed? Most definitely, but if safety requires slowing down to human speed, then we should definitely do that. And I'm sure tools can emerge to increase the efficiency of the review without compromising its quality, if they are needed.

On indicators: post-2008 bank regulation made regulators proactive. Instead of waiting for a bank's failure, at the irreversible or bailout point, countermeasures are required up front. In AI, we could use independent auditors testing models' AI R&D capabilities before internal use, with restrictions automatically triggered at a set threshold. Same objective safety standard for all.

I just wrote about ex ante liability for AI labs from a finance law perspective. Would love to compare notes. I think we also agree that Ezra is doing great work bringing good insights to the public.

No posts

Ready for more?